A

Arbutus Biopharma Corp

D
ABUS
USD
-0.195
(-4.9618%)
Market Closed
53,668.00
Volume
-0.46028
EPS
-
Div Yield
-8.355556
P/E
705,100,878.32
Market Cap
Today
-4.9618%
1 Week
-2.734%
1 Month
0.268%
6 Months
31.746%
12 Months
101.892%
Year To Date
49.699%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ALNY
ALNY
-0.795
(-0.2913%)
USD
D
DRNA
(%)
USD
A
ARWR
0.055
(0.2579%)
USD
MRNA
MRNA
-0.985
(-1.921%)
USD
A
ADVM
-0.15
(-1.8634%)
USD
V
VBIV
(%)
USD
S
SRNE
(%)
USD
REGN
REGN
8.505
(1.0417%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
GILD
GILD
6.23
(6.7946%)
USD
BMY
BMY
-1.66
(-2.9454%)
USD

Title:
Arbutus Biopharma Corp

Sector:
Healthcare
Industry:
Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Do you need help or have a question?
Contact Us